{"id":969722,"date":"2026-06-02T16:10:08","date_gmt":"2026-06-02T20:10:08","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/crinetics-and-leading-patient-groups-launch-everyday-advocacy-initiative-to-empower-people-across-endocrine-disease-communities\/"},"modified":"2026-06-02T16:10:08","modified_gmt":"2026-06-02T20:10:08","slug":"crinetics-and-leading-patient-groups-launch-everyday-advocacy-initiative-to-empower-people-across-endocrine-disease-communities","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/crinetics-and-leading-patient-groups-launch-everyday-advocacy-initiative-to-empower-people-across-endocrine-disease-communities\/","title":{"rendered":"Crinetics and Leading Patient Groups Launch \u2018Everyday Advocacy\u2019 Initiative to Empower People Across Endocrine Disease Communities"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"center\">\n        <em>Everyday Advocacy provides people living with endocrine and endocrine-related conditions with education, support, and tools to facilitate more impactful healthcare team interactions<\/em>\n      <\/p>\n<p align=\"center\">\n        <em>Steering committee of five leading patient organizations to guide program with authentic perspectives and insights into most significant patient needs<\/em>\n      <\/p>\n<p>SAN DIEGO, June  02, 2026  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=kEHQRDxI0IDBeK9pHKWDMuSKXSe7pnuyPA6haWug3SEXshboYeTWwZZBekT-XltKku35ygQfCy0Ovgtye9u1mbKACWcTDtiAu1unJfU6JVo=\" rel=\"nofollow\" target=\"_blank\"><u>Crinetics Pharmaceuticals, Inc.<\/u><\/a> (Nasdaq: CRNX) today announced the launch of Everyday Advocacy, a new initiative designed to support patient education, self-advocacy, and connection within endocrine disease communities.<\/p>\n<p>\u201cCrinetics is led by a conviction that meaningful progress for endocrine disease treatment begins with listening to patients and understanding their unique lived experiences,\u201d said Jacqueline Kirby, Chief Corporate Affairs Officer of Crinetics. \u201cEveryday Advocacy builds on the long-standing relationships we\u2019ve built with patient communities in underserved areas of endocrinology and will offer educational resources and opportunities that support informed, confident participation in care.\u201d<\/p>\n<p>Everyday Advocacy was developed with input from advocacy partners and patient leadership councils representing several endocrine and endocrine-related conditions. A steering committee of patient advocacy groups, including Acromegaly Community, CARES Foundation, Cushing\u2019s Support &amp; Research Foundation, Neuroendocrine Cancer Foundation, and Pituitary World News will help inform and guide the evolution of Everyday Advocacy\u2019s content and resources.<\/p>\n<p>Key elements of the Everyday Advocacy initiative will include:<\/p>\n<ul type=\"disc\">\n<li>\n          <strong>Digital resources and free signature tools <\/strong>to support self-advocacy in everyday healthcare interactions. This includes the Acromegaly Symptom Diary mobile app designed to help individuals track and notice potential breakthrough symptoms.<\/li>\n<li>\n          <strong>Online and in-person workshops<\/strong> focused on facilitating peer connection and helping individuals better understand their health condition, navigate the healthcare system, and engage in informed discussions with their healthcare providers.<\/li>\n<li>\n          <strong>Ongoing partnership with leading patient advocacy organizations<\/strong> to help ensure Everyday Advocacy\u2019s content and resources remain relevant and responsive to changing patient needs.<\/li>\n<li>\n          <strong>A scalable platform<\/strong> initially focused on acromegaly, with planned expansion into additional endocrine and endocrine-related disease areas beginning in 2027.<\/li>\n<\/ul>\n<p>\u201cPeople living with acromegaly often spend years searching for answers, and even after diagnosis, navigating care can feel overwhelming,\u201d said Jill Sisco, President of Acromegaly Community. \u201cEveryday Advocacy meets patients where they are, with practical tools, meaningful community support, and resources designed to help patients navigate the challenges they face every day. Acromegaly Community is proud to be a part of an initiative that reflects a genuine, long-term commitment to people living with acromegaly.\u201d<\/p>\n<p>Four live workshops focused on self-advocacy education and practical tools for people living with acromegaly will be held this year, with additional details to be announced soon. Beginning in 2027, additional workshops will expand the program to support people living with other endocrinology conditions and neuroendocrine cancers.<\/p>\n<p>\u201cCARES Foundation is excited to join this dynamic group in an initiative that puts patients first by providing practical resources and support for the everyday realities of managing care,\u201d said Dina Matos, Executive Director, CARES Foundation. \u201cPeople living with congenital adrenal hyperplasia often have to become experts in their care while navigating a complex, lifelong condition. Everyday Advocacy aims to help shift that dynamic by giving patients the tools and confidence to engage with their healthcare teams as true partners.\u201d<\/p>\n<p>Everyday Advocacy complements Crinetics\u2019 commitment to patient-focused innovation and reinforces the Company\u2019s long-term vision to improve outcomes for people living with endocrine disorders. For more information, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=scUjy5Of5fTtK_IByFqA9HDJg5DxPZ8vLQa4pqkdPvSROzPMaU5cY7kNcshicMDXOGos5zO_efBTf6x9aPgYDdnLJX2NtJR8XPyT2mXP3tbsCHCEgfedbPofXepBMRYi\" rel=\"nofollow\" target=\"_blank\">www.EverydayAdvocacy.com<\/a><\/p>\n<p>\n        <strong>About Crinetics Pharmaceuticals<\/strong><br \/>\n        <br \/>Crinetics Pharmaceuticals is a global pharmaceutical company committed to transforming the treatment of endocrine diseases and endocrine-related tumors through science rooted in patient needs. Crinetics is focused on discovering, developing, and commercializing novel therapies, with a core expertise in targeting G-protein coupled receptors (GPCRs) with small molecules that have specifically tailored pharmacology and properties.<\/p>\n<p>Crinetics\u2019 first commercial product, PALSONIFY\u2122 (paltusotine), is the first once-daily, oral treatment approved by the U.S. FDA and EMA for the treatment of adults with acromegaly who had an inadequate response to surgery and\/or for whom surgery is not an option. Paltusotine is also in clinical development for carcinoid syndrome associated with neuroendocrine tumors. Crinetics\u2019 deep pipeline of 10+ disclosed programs includes late-stage investigational candidate atumelnant, which is currently in development for congenital adrenal hyperplasia and ACTH-dependent Cushing\u2019s syndrome, and CRN09682, a nonpeptide drug conjugate candidate that is being developed to treat somatostatin receptor 2 (SST2) expressing neuroendocrine tumors and other SST2 expressing solid tumors. Additional discovery programs are focused on a variety of endocrine targets such as thyroid stimulating hormone (TSH), parathyroid hormone (PTH), somatostatin receptor 3 (SST3), growth hormone (GH), glucagon-like peptide-1 (GLP-1), and glucose-dependent insulinotropic polypeptide (GIP), as well as GPCR-targeted oncology indications.<\/p>\n<p>\n        <strong>Investors:<\/strong><br \/>\n        <br \/>\n        <strong>Media:<\/strong><br \/>\n        <br \/>Natalie Badillo<br \/>Head of Corporate Communications<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=bk3siYIVZyijy0R0eDbrrSsfoALHDJ9bmdOsjuoaurauwzUpOX8w2of26EQlPtc01FgsffnJUcE5tlukA0Lt-r3Cr3FxBewGeqiEtzA3byI=\" rel=\"nofollow\" target=\"_blank\">nbadillo@crinetics.com<\/a><br \/>(858) 345-6075<\/p>\n<p>Gayathri Diwakar<br \/>Head of Investor Relations<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ieqbud_9wXz1MKqQjblQLFZkBuN0pt5kuf9ZD27cntV21z8FAgzaxfjpFCVQBoZWXkGJIDMi4_yXJg2QvoLT_2xzHJbxpJANDlhmwf0_y-M=\" rel=\"nofollow\" target=\"_blank\">gdiwakar@crinetics.com<\/a><br \/>(858) 345-6340<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTczMDE1MSM3NjMwOTM2IzIwODk4MTU=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ZDc5ODVmM2YtNWRmOS00NzlhLTljMTItNWM1MGE4MjQwNzEzLTExMDEzODYtMjAyNi0wNi0wMi1lbg==\/tiny\/Crinetics-Pharmaceuticals-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Everyday Advocacy provides people living with endocrine and endocrine-related conditions with education, support, and tools to facilitate more impactful healthcare team interactions Steering committee of five leading patient organizations to guide program with authentic perspectives and insights into most significant patient needs SAN DIEGO, June 02, 2026 (GLOBE NEWSWIRE) &#8212; Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced the launch of Everyday Advocacy, a new initiative designed to support patient education, self-advocacy, and connection within endocrine disease communities. \u201cCrinetics is led by a conviction that meaningful progress for endocrine disease treatment begins with listening to patients and understanding their unique lived experiences,\u201d said Jacqueline Kirby, Chief Corporate Affairs Officer of Crinetics. \u201cEveryday Advocacy builds on the long-standing relationships we\u2019ve built with &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/crinetics-and-leading-patient-groups-launch-everyday-advocacy-initiative-to-empower-people-across-endocrine-disease-communities\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Crinetics and Leading Patient Groups Launch \u2018Everyday Advocacy\u2019 Initiative to Empower People Across Endocrine Disease Communities&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-969722","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Crinetics and Leading Patient Groups Launch \u2018Everyday Advocacy\u2019 Initiative to Empower People Across Endocrine Disease Communities - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/crinetics-and-leading-patient-groups-launch-everyday-advocacy-initiative-to-empower-people-across-endocrine-disease-communities\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Crinetics and Leading Patient Groups Launch \u2018Everyday Advocacy\u2019 Initiative to Empower People Across Endocrine Disease Communities - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Everyday Advocacy provides people living with endocrine and endocrine-related conditions with education, support, and tools to facilitate more impactful healthcare team interactions Steering committee of five leading patient organizations to guide program with authentic perspectives and insights into most significant patient needs SAN DIEGO, June 02, 2026 (GLOBE NEWSWIRE) &#8212; Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced the launch of Everyday Advocacy, a new initiative designed to support patient education, self-advocacy, and connection within endocrine disease communities. \u201cCrinetics is led by a conviction that meaningful progress for endocrine disease treatment begins with listening to patients and understanding their unique lived experiences,\u201d said Jacqueline Kirby, Chief Corporate Affairs Officer of Crinetics. \u201cEveryday Advocacy builds on the long-standing relationships we\u2019ve built with &hellip; Continue reading &quot;Crinetics and Leading Patient Groups Launch \u2018Everyday Advocacy\u2019 Initiative to Empower People Across Endocrine Disease Communities&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/crinetics-and-leading-patient-groups-launch-everyday-advocacy-initiative-to-empower-people-across-endocrine-disease-communities\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-02T20:10:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTczMDE1MSM3NjMwOTM2IzIwODk4MTU=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crinetics-and-leading-patient-groups-launch-everyday-advocacy-initiative-to-empower-people-across-endocrine-disease-communities\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crinetics-and-leading-patient-groups-launch-everyday-advocacy-initiative-to-empower-people-across-endocrine-disease-communities\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Crinetics and Leading Patient Groups Launch \u2018Everyday Advocacy\u2019 Initiative to Empower People Across Endocrine Disease Communities\",\"datePublished\":\"2026-06-02T20:10:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crinetics-and-leading-patient-groups-launch-everyday-advocacy-initiative-to-empower-people-across-endocrine-disease-communities\\\/\"},\"wordCount\":781,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crinetics-and-leading-patient-groups-launch-everyday-advocacy-initiative-to-empower-people-across-endocrine-disease-communities\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTczMDE1MSM3NjMwOTM2IzIwODk4MTU=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crinetics-and-leading-patient-groups-launch-everyday-advocacy-initiative-to-empower-people-across-endocrine-disease-communities\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crinetics-and-leading-patient-groups-launch-everyday-advocacy-initiative-to-empower-people-across-endocrine-disease-communities\\\/\",\"name\":\"Crinetics and Leading Patient Groups Launch \u2018Everyday Advocacy\u2019 Initiative to Empower People Across Endocrine Disease Communities - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crinetics-and-leading-patient-groups-launch-everyday-advocacy-initiative-to-empower-people-across-endocrine-disease-communities\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crinetics-and-leading-patient-groups-launch-everyday-advocacy-initiative-to-empower-people-across-endocrine-disease-communities\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTczMDE1MSM3NjMwOTM2IzIwODk4MTU=\",\"datePublished\":\"2026-06-02T20:10:08+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crinetics-and-leading-patient-groups-launch-everyday-advocacy-initiative-to-empower-people-across-endocrine-disease-communities\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crinetics-and-leading-patient-groups-launch-everyday-advocacy-initiative-to-empower-people-across-endocrine-disease-communities\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crinetics-and-leading-patient-groups-launch-everyday-advocacy-initiative-to-empower-people-across-endocrine-disease-communities\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTczMDE1MSM3NjMwOTM2IzIwODk4MTU=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTczMDE1MSM3NjMwOTM2IzIwODk4MTU=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crinetics-and-leading-patient-groups-launch-everyday-advocacy-initiative-to-empower-people-across-endocrine-disease-communities\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Crinetics and Leading Patient Groups Launch \u2018Everyday Advocacy\u2019 Initiative to Empower People Across Endocrine Disease Communities\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Crinetics and Leading Patient Groups Launch \u2018Everyday Advocacy\u2019 Initiative to Empower People Across Endocrine Disease Communities - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/crinetics-and-leading-patient-groups-launch-everyday-advocacy-initiative-to-empower-people-across-endocrine-disease-communities\/","og_locale":"en_US","og_type":"article","og_title":"Crinetics and Leading Patient Groups Launch \u2018Everyday Advocacy\u2019 Initiative to Empower People Across Endocrine Disease Communities - Market Newsdesk","og_description":"Everyday Advocacy provides people living with endocrine and endocrine-related conditions with education, support, and tools to facilitate more impactful healthcare team interactions Steering committee of five leading patient organizations to guide program with authentic perspectives and insights into most significant patient needs SAN DIEGO, June 02, 2026 (GLOBE NEWSWIRE) &#8212; Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced the launch of Everyday Advocacy, a new initiative designed to support patient education, self-advocacy, and connection within endocrine disease communities. \u201cCrinetics is led by a conviction that meaningful progress for endocrine disease treatment begins with listening to patients and understanding their unique lived experiences,\u201d said Jacqueline Kirby, Chief Corporate Affairs Officer of Crinetics. \u201cEveryday Advocacy builds on the long-standing relationships we\u2019ve built with &hellip; Continue reading \"Crinetics and Leading Patient Groups Launch \u2018Everyday Advocacy\u2019 Initiative to Empower People Across Endocrine Disease Communities\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/crinetics-and-leading-patient-groups-launch-everyday-advocacy-initiative-to-empower-people-across-endocrine-disease-communities\/","og_site_name":"Market Newsdesk","article_published_time":"2026-06-02T20:10:08+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTczMDE1MSM3NjMwOTM2IzIwODk4MTU=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crinetics-and-leading-patient-groups-launch-everyday-advocacy-initiative-to-empower-people-across-endocrine-disease-communities\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crinetics-and-leading-patient-groups-launch-everyday-advocacy-initiative-to-empower-people-across-endocrine-disease-communities\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Crinetics and Leading Patient Groups Launch \u2018Everyday Advocacy\u2019 Initiative to Empower People Across Endocrine Disease Communities","datePublished":"2026-06-02T20:10:08+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crinetics-and-leading-patient-groups-launch-everyday-advocacy-initiative-to-empower-people-across-endocrine-disease-communities\/"},"wordCount":781,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crinetics-and-leading-patient-groups-launch-everyday-advocacy-initiative-to-empower-people-across-endocrine-disease-communities\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTczMDE1MSM3NjMwOTM2IzIwODk4MTU=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crinetics-and-leading-patient-groups-launch-everyday-advocacy-initiative-to-empower-people-across-endocrine-disease-communities\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/crinetics-and-leading-patient-groups-launch-everyday-advocacy-initiative-to-empower-people-across-endocrine-disease-communities\/","name":"Crinetics and Leading Patient Groups Launch \u2018Everyday Advocacy\u2019 Initiative to Empower People Across Endocrine Disease Communities - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crinetics-and-leading-patient-groups-launch-everyday-advocacy-initiative-to-empower-people-across-endocrine-disease-communities\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crinetics-and-leading-patient-groups-launch-everyday-advocacy-initiative-to-empower-people-across-endocrine-disease-communities\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTczMDE1MSM3NjMwOTM2IzIwODk4MTU=","datePublished":"2026-06-02T20:10:08+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crinetics-and-leading-patient-groups-launch-everyday-advocacy-initiative-to-empower-people-across-endocrine-disease-communities\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/crinetics-and-leading-patient-groups-launch-everyday-advocacy-initiative-to-empower-people-across-endocrine-disease-communities\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crinetics-and-leading-patient-groups-launch-everyday-advocacy-initiative-to-empower-people-across-endocrine-disease-communities\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTczMDE1MSM3NjMwOTM2IzIwODk4MTU=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTczMDE1MSM3NjMwOTM2IzIwODk4MTU="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crinetics-and-leading-patient-groups-launch-everyday-advocacy-initiative-to-empower-people-across-endocrine-disease-communities\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Crinetics and Leading Patient Groups Launch \u2018Everyday Advocacy\u2019 Initiative to Empower People Across Endocrine Disease Communities"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/969722","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=969722"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/969722\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=969722"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=969722"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=969722"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}